Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIFART
2007-007935-14Phase 4Terminated
- Sponsor
- ASST Spedali Civili di Brescia
- Start
- Jan 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of rifampicin, rifabutin, efavirenz, lopinavir, ritonavir and 2 more in human immunodeficiency virus infection (HIV) and Tuberculosis (TB) (2 arms), sponsored by ASST Spedali Civili di Brescia. Primary endpoint: Adherence rate comparison. Started Jan 2008; status: terminated.
02
Drugs
rifampicinrifabutinefavirenzlopinavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)Tuberculosis (TB)
Beyond the preview
Go deeper on 2007-007935-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007935-14.